Found 25 matching trials
A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia PHASE1 To assess the pharmacokinetics and safety of aripiprazole intra-muscular (I...
Show More Location
Multiple Locations
Learn More & Join Trial
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder PHASE3 This will be an open-label uncontrolled trial to evaluate the safety and to...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia PHASE1 This trial will determine the Pharmacokinetics, safety and tolerability of ...
Show More Location
Woodland International Research Group
Learn More & Join Trial
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole PHASE3 The purpose of this study is to compare retrospective hospitalization rates...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia PHASE1 To determine the safety and tolerability of multiple-dose administrations o...
Show More Location
Comprehensive Clinical Development
Learn More & Join Trial
An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia PHASE3 The primary objective of this study was to continue to provide aripiprazole...
Show More Location
Multiple Locations
Learn More & Join Trial
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia PHASE3 The phase 3 Trial 31-12-291 is part of the aripiprazole IM depot clinical d...
Show More Location
Multiple Locations
Learn More & Join Trial
A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder PHASE1 The purpose of this trial is to determine the safety and tolerability of mu...
Show More Location
Woodland International Research Group
Learn More & Join Trial
Aripiprazole IM Depot for Chinese Patients With Schizophrenia PHASE1 This study assess pharmacokinetics and safety of single-administration of A...
Show More Location
Beijing Anding Hospital of Capital Medical University
Learn More & Join Trial
An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia PHASE1 The purpose of this study is to determine whether aripiprazole injection in...
Show More Location
Comprehensive Clinical Development, Inc.
Learn More & Join Trial